Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic

Overview

Emergency general surgical care during the COVID-19 pandemic presents a unique set of considerations and challenges. Patients presenting with acute surgical conditions and concomitant COVID-19 infection have higher risk of mortality and morbidity. We present our institution's experience with COVID-19 positive patients presenting with acute surgical conditions and reviewed the implementation of a protocolized pathway to mitigate the impact of COVID-19 infection.

Full Title of Study: “Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic Based on Case Series”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: May 31, 2020

Detailed Description

All COVID-19 positive patients who presented to the acute general surgical service over a 2-month period were identified. Patient data including demographics, surgical diagnosis, mortality, morbidity and hospital length of stay was collected. Based on our early experience from the first patient, we designed a protocolized institutional pathway which incorporated the risk of COVID-19 infection and urgency of operation.

Interventions

  • Procedure: Emergency surgery
    • Emergency surgery vs conservative management

Clinical Trial Outcome Measures

Primary Measures

  • Surgical morbidity in patients with COVID-19 infection and general surgical conditions
    • Time Frame: Follow up 1 month

Participating in This Clinical Trial

Inclusion Criteria

  • All patients with emergency surgical conditions and tested positive for COVID-19 infection

Exclusion Criteria

  • Nil

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Khoo Teck Puat Hospital
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.